Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)
Clinical trial NCT03046979 · UNKNOWN
Trial details
- NCT number
- NCT03046979
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2017-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.